CNNAOTCHealthcare · Drug Manufacturers - Specialty & Generic

Cann American Corp.

$0.00+0.00%(+$0.00)

TickerSpark Score

29/100

Poor

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNNA research report →

52-Week Range3% of range

Low $0.00

Current $0.00

High $0.02

Companywww.cannamericancorp.com

Cann American Corp. , a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc.

CEO: Jason R. Tucker
IPO: 2011
Employees: 1
HQ: Cloverdale, CA, US

Price Chart

-79.49% · this period

Valuation

Market Cap: $590.27K
P/E: 0.06
P/S: 0.00
P/B: -0.09
EV/EBITDA: 0.00
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -80.82%
ROIC: 5.92%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $3.82K · -63.75%
EPS: $0.01 · -72.61%
Op Income: $-145
FCF YoY: 101.47%

Performance & Tape

52W High: $0.02
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -0.77
Avg Volume: 372.13K

Get TickerSpark's AI analysis on CNNA

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Jan 25, 11	DAHLERUP HENRIK	director, 10 percent owner, officer: COO	other	0	—
Jan 25, 11	SCHIORRING KRISTIAN	director, 10 percent owner, officer: CEO, CFO	other	0	—
Jan 25, 11	WONG GARRY E	director	sell	12,856,667	$1.29K
Jan 25, 11	WONG GARRY E	director	sell	75,643,333	$0
Jan 25, 11	WONG GARRY E	director	other	0	—